ETP ALL, or early T-cell precursor ALL, is a distinct form of leukemia characterized by reduced expression of T-cell markers (CD1a, CD8, and CD5) and aberrant expression of myeloid or stem-cell markers [144]. Here, CD1A is linked to acute lymphoblastic leukemia.